BST1
Basic information
Region (hg38): 4:15703064-15738313
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (15 variants)
- not provided (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BST1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 14 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 14 | 3 | 4 |
Variants in BST1
This is a list of pathogenic ClinVar variants found in the BST1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-15703170-C-G | not specified | Uncertain significance (Oct 02, 2023) | ||
4-15703202-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
4-15703236-G-C | not specified | Likely benign (Oct 20, 2023) | ||
4-15703287-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
4-15703301-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
4-15703328-C-G | not specified | Uncertain significance (May 11, 2022) | ||
4-15705586-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
4-15705627-A-G | Benign (Dec 31, 2019) | |||
4-15705635-A-C | not specified | Uncertain significance (Apr 11, 2023) | ||
4-15707553-G-A | not specified | Uncertain significance (Jul 07, 2022) | ||
4-15707565-C-T | Benign (Jun 13, 2018) | |||
4-15707566-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
4-15707568-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
4-15707585-C-G | not specified | Uncertain significance (Jan 31, 2023) | ||
4-15707630-A-G | Benign (Aug 20, 2018) | |||
4-15707635-A-G | not specified | Uncertain significance (May 31, 2022) | ||
4-15711854-C-G | not specified | Likely benign (Jun 06, 2023) | ||
4-15711875-A-G | not specified | Uncertain significance (Dec 13, 2021) | ||
4-15715300-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
4-15715303-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
4-15715340-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
4-15715757-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
4-15715758-A-G | Likely benign (Jul 29, 2018) | |||
4-15715789-G-A | Likely benign (May 11, 2018) | |||
4-15715792-C-T | not specified | Uncertain significance (Apr 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BST1 | protein_coding | protein_coding | ENST00000265016 | 9 | 35364 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.21e-11 | 0.101 | 125621 | 0 | 126 | 125747 | 0.000501 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.103 | 173 | 169 | 1.02 | 0.00000930 | 2036 |
Missense in Polyphen | 55 | 57.959 | 0.94895 | 738 | ||
Synonymous | 0.739 | 64 | 72.0 | 0.889 | 0.00000459 | 614 |
Loss of Function | 0.378 | 17 | 18.8 | 0.906 | 0.00000114 | 189 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000798 | 0.000798 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00201 | 0.00201 |
Finnish | 0.000371 | 0.000370 |
European (Non-Finnish) | 0.000398 | 0.000396 |
Middle Eastern | 0.00201 | 0.00201 |
South Asian | 0.000454 | 0.000392 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Synthesizes the second messagers cyclic ADP-ribose and nicotinate-adenine dinucleotide phosphate, the former a second messenger that elicits calcium release from intracellular stores. May be involved in pre-B-cell growth. {ECO:0000269|PubMed:11866528}.;
- Pathway
- Nicotinate and nicotinamide metabolism - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Nicotinate and Nicotinamide Metabolism;NAD+ biosynthetic pathways;Neutrophil degranulation;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins;Vitamin B3 (nicotinate and nicotinamide) metabolism;Innate Immune System;Immune System;Metabolism;Nicotinate Nicotinamide metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.198
Intolerance Scores
- loftool
- 0.853
- rvis_EVS
- 0.86
- rvis_percentile_EVS
- 88.69
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.515
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bst1
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- regulation of cell-matrix adhesion;regulation of cellular extravasation;humoral immune response;signal transduction;positive regulation of cell population proliferation;NAD metabolic process;positive regulation of B cell proliferation;regulation of actin cytoskeleton organization;neutrophil degranulation;regulation of inflammatory response;regulation of peptidyl-tyrosine phosphorylation;regulation of calcium-mediated signaling;regulation of neutrophil chemotaxis;regulation of superoxide metabolic process;regulation of integrin-mediated signaling pathway
- Cellular component
- uropod;extracellular region;plasma membrane;integrin complex;extrinsic component of membrane;anchored component of membrane;specific granule membrane;extracellular exosome
- Molecular function
- NAD+ nucleosidase activity;transferase activity;phosphorus-oxygen lyase activity;NAD(P)+ nucleosidase activity;NAD+ nucleotidase, cyclic ADP-ribose generating;ADP-ribosyl cyclase activity;cyclic ADP-ribose hydrolase